High-dose aspirin is required to influence plasma fibrin network structure in patients with type 1 diabetes

about

Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk.Anti-inflammatory therapy in type 1 diabetes.Assessment of the Procoagulant Activity of Microparticles and the Protein Z System in Patients Undergoing Off-Pump Coronary Artery Bypass Surgery.

P2860

Q37692590-A72014EC-BE55-4479-AEFC-45685E115ED5 Q38025979-4E2E064A-62AA-4A5F-9AAF-5D926D429773 Q51024042-1387ABE6-CD54-45A9-A2AB-F0443F6DAFFE

P2860

High-dose aspirin is required to influence plasma fibrin network structure in patients with type 1 diabetes

Item

http://www.wikidata.org/entity/Q35688330

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

High-dose aspirin is required ...... patients with type 1 diabetes

@ast

High-dose aspirin is required ...... patients with type 1 diabetes

@en

type

Item

label

High-dose aspirin is required ...... patients with type 1 diabetes

@ast

High-dose aspirin is required ...... patients with type 1 diabetes

@en

prefLabel

High-dose aspirin is required ...... patients with type 1 diabetes

@ast

High-dose aspirin is required ...... patients with type 1 diabetes

@en

P1476

High-dose aspirin is required ...... patients with type 1 diabetes

@en

P2093

Aleksandra Antovic

http://www.w3.org/2001/XMLSchema#string

Fariborz Mobarrez

http://www.w3.org/2001/XMLSchema#string

Gun Jörneskog

http://www.w3.org/2001/XMLSchema#string

Håkan N Wallén

http://www.w3.org/2001/XMLSchema#string

Koteiba Mageed

http://www.w3.org/2001/XMLSchema#string

Per-Eric Lins

http://www.w3.org/2001/XMLSchema#string

Sara Tehrani

http://www.w3.org/2001/XMLSchema#string

Ulf Adamson

http://www.w3.org/2001/XMLSchema#string

P2860

Marked increase of fibrin gel permeability with very low dose ASA treatment

Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions

Modifications of flow measurement to determine fibrin gel permeability and the preliminary use in research and clinical materials

Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin

The principal site of nonenzymatic glycosylation of human serum albumin in vivo

Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers.

Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature.

Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia.

A multicolor flow cytometric assay for measurement of platelet-derived microparticles.

Increased plasma fibrin gel porosity in patients with Type I diabetes during continuous subcutaneous insulin infusion.

P304

404-408

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC11-1302

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51858794

http://www.w3.org/2001/XMLSchema#string

P698

22148098

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

aspirin

P932

3263903

http://www.w3.org/2001/XMLSchema#string

High-dose aspirin is required to influence plasma fibrin network structure in patients with type 1 diabetes

about

P2860

P2860

High-dose aspirin is required to influence plasma fibrin network structure in patients with type 1 diabetes

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932